Novartis (NVS) Announces Receipt of Three New FDA Approvals for Expanded Use of Ilaris
Go back to Novartis (NVS) Announces Receipt of Three New FDA Approvals for Expanded Use of IlarisNOVARTIS AG (NYSE: NVS) | Delayed: 95.88 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $95.88 | 52 Week High | $89.15 | |||
Open | $95.88 | 52 Week Low | $69.84 | |||
Day High | $95.88 | P/E | N/A | |||
Day Low | $95.88 | EPS | $0.00 | |||
Volume | 3,093 |